Efficacy of quercetin derivatives in prevention of ulcerative colitis in rats

Open access

Abstract

Reactive oxygen species has been implicated to contribute significantly to tissue injury associated with ulcerative colitis. Thus compounds with antioxidant properties could be potential therapeutic agents in this disease. Flavonoid compounds are known to possess antioxidative and antiinflammatory properties. Two derivatives of the flavonoid quercetin (Q), chloronaphthoquinone quercetin (CNC) and monochloropivaloyl quercetin (MCP), showed improved antioxidant properties and moreover, they efficiently inhibited aldose reductase activity in vitro. The aim of the work was to test the potential efficacy of quercetin and these synthetic derivatives in vivo in prevention of intestinal inflammation during ulcerative colitis in rats. Colitis was induced by intracolonic administration of acetic acid (4% solution). The control group received the same volume of saline. The vehicle dimethyl sulfoxide (DMSO) and the drugs Q, CNC or MCP were administered orally two hours and then one hour before the acetic acid or saline instillation. After 48 hours, the animals were sacrificed and the colon was weighed, measured and scored for visible damage. Acetic acid triggered an intense inflammatory response of the colon, characterised by haemorrhage, ulceration and bowel wall thickening. From the drugs tested, only CNC (2 × 50 mg/kg) effectively depressed inflammatory damage of the colon. The mechanism of this beneficial effect remains to be elucidated.

Alarcón de la Lastra C, Martin MJ and Motilva V. (1994). Antiulcer and gastroprotective effects of quercetin: a gross and histologic study. Pharmacology48: 56-62.

Amić D, Davidović-Amić D, Beslo D, Rastija V, Lucić B and Trinajstić N. (2007). SAR and QSAR of the antioxidant activity of flavonoids. Curr Med Chem 14: 827-845.

Bonacorsi C, Raddi MS, da Fonseca LM, Sannomiya M and Vilegas W. (2012). Effect of Byrsonima crassa and phenolic constituents on Helicobacter pylori- induced neutrophils oxidative burst. Int J Mol Sci 13: 133-141.

Boots AW, Haenen GRMM and Bast A. (2008). Health effects of quercetin: From antioxidant to nutraceutical. Eur J Pharm 585: 325-337.

Butkovic V, Klasinc L and Bors W. (2004). Kinetic study of flavonoid reactions with stable radicals. J Agric Food Chem 52: 2816-2820.

Camuesco D, Comalada M, Rodrıguez-Cabezas ME, Nieto A, Lorente MD, Concha A, Zarzuelo A and Galvez J. (2004). The intestinal antiinflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br JPharmacol 143: 908-918.

Guazelli CF, Fattori V, Colombo BB, Georgetti SR, Vicentini FT, Casagrande R, Baracat MM and Verri WA Jr. (2013). Quercetin-loaded microcapsules ameliorate experimental colitis in mice by antiinflammatory and antioxidant mechanisms. J Nat Prod 76(2): 200-208.

Hemnani T and Parihar MS. (1998). Reactive oxygen species and oxidative DNA damage. Indian J Physiol Pharmacol 42: 440-452.

Chang KC, Laffin B, Ponder J, Enzsoly A, Nemeth J, Labarbera DV and Petrash JM. (2012). Beta-glucogallin reduces the expression of lipopolysaccharideinduced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues. Chem Biol Interact [Epub ahead of print]

Chuang CC, Martinez K, Xie G, Kennedy A, Bumrungpert A, Overman A, Jia W and McIntosh MK. (2010). Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr 92: 1511-1521.

Jacob SW and de la Torre JC. (2009). Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol Rep 61: 225-35.

Keshavarzian A, Haydek J, Zabihi R, Doria M, D’Astice M and Sorensen JRJ. (1992). Agents capable of eliminating reactive oxygen species: catalase, WR-2721, Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig Dis Sci 37: 1866-1873.

Keshavarzian A, Morgan G, Sedghi S, Gordon JH and Doria M. (1990). Role of reactive oxygen metabolites in experimental colitis. Gut 31: 786-790.

Kim HP, Mani I and Ziboh VA.(1958). Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase from guinea pigs. ProstaglandinsLeukot Essent Fatty Acids 58: 17-24.

Lee KM, Hwang MK, Lee DE, Lee KW and Lee HJ (2010). Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 58: 5815-5820.

Loguercio C, D’Argenio G, Delle Cave M, Cosenza V, Della Valle N and Mazzcca Blanco CV. (1996). Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig Dis Sci 41: 1204-1211.

MacPherson BR and Pfeiffer CJ. (1978). Experimental production of diffuse colitis in rats. Digestion 17: 135-150.

Middleton EJ.(2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.

Morikawa K, Nonaka M, Narahara M, Torii I, Kawaguchi K, Yoshikawa T, Kumazawa Y and Morikawa S. (2003). Inhibitory effect of quercetin on carrageenan- induced inflammation in rats. Life Sci 74: 709-721.

Najafzadeh M, Reynolds PD, Baumgartner A and Anderson D. (2009). Flavonoids inhibit the genotoxicity of hydrogen peroxide (H2O2) and of the food mutagen 2-amino-3 methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD). Mutagenesis24: 405-411.

Noa M, Mas R, Carbaja,D and Valdes S. (2000). Effect of D-002 on acetic acidinduced colitis in rats at single and repeated doses. Pharmacol Res 41: 391-395.

Nosal’ova V, Zeman M, Černa S, Navarova J and Zakalova M. (2007). Protective effect of melatonin in acetic acid induced colitis in rats. J Pineal Res 42: 364-370.

Ortega MG, Saragusti AC, Cabrera JL and Chiabrando GA. (2010). Quercetin tetraacetyl derivative inhibits LPS-induced nitric oxide synthase (iNOS) expression in J774A.1 cells. Arch Biochem Biophys 498: 105-110.

Rachmilewitz D, Simon PL, Schwartz LW, Griswald DE, Fondacaro JD and Wasserman MA. (1989). Inflammatory mediators of experimental colitis in rats. Gastroenterology 97: 326-327.

Rezaie A, Parker RD and Abdollahi M. (2007). Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? DigDis Sci 52: 2015-2021.

Sanchez de Medina F, Galvez J, Romero JA and Zarzuelo A. (1996). Effect of quercitrin on acute and chronic experimental colitis in the rat. J PharmacolExp Ther 278: 771-779.

Sanchez de Medina F, Vera B, Galvez J and Zarzuelo A. (2002). Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci 70: 3097-3108.

Santos NC, Figueira-Coelho J, Martins-Silva J and Saldanha C. (2003). Multidisciplinary utilization of dimethyl sulfoxide: pharmaclogical, cellular and molecular aspects. Biochem Pharmacol 65: 1035-1041.

Veverka M, Gallovič J, Švajdlenka E, Veverkova E, Pronayova N, Milačkova I and Štefek M. (2013). Novel quercetin derivatives: synthesis and screening for anti-oxidant activity and aldose reductase inhibition. Chem Papers 67: 76-83.

Xiao ZP, Wang XD, Peng ZY, Huang S, Yang P, Li QS, Zhou LH, Hu XJ, Wu LJ, Zhou Y and Zhu HL. (2012). Molecular docking, kinetics study, and structure- activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors. J Agric Food Chem 60: 10572-10577.

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences

Journal Information


CiteScore 2018: 1.78

SCImago Journal Rank (SJR) 2018: 0.274
Source Normalized Impact per Paper (SNIP) 2018: 0.671

Cited By

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 293 229 14
PDF Downloads 131 102 12